MedicQuant seed round advances AU DNA nanotechnology for acute-care diagnostics

MedicQuant, a spinout from iNANO and the Department of Chemistry at Aarhus University, has secured new seed funding to advance a diagnostic platform rooted in more than 11 years of research. Built on DNA nanotechnology, the company’s point-of-care system aims to deliver rapid, laboratory-accurate drug measurements in acute clinical settings.